Edgemont launches new higher dose bupropion extended-release tablets
The Forfivo XL, which the company claims, is the only available 450mg dose of an extended-release bupropion product and is intended for the treatment of major depressive disorder
Novartis has signed an agreement to purchase Myricx Bio, a UK-based biotechnology company, in a transaction valued at up to $1.5bn.
Magnesium-enriched SoyLife product, which is produced by Israel-based Frutarom company, is a proprietary soy germ extract designed to support well-being of women experiencing menopausal symptoms. Multiple scientific studies